For patients with lung cancer, biomarker testing may be an option.

The majority of Europeans can’t identify the warning signs of heart failure, a life threatening disease, which affects one in five people in the region.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.